Author:
Chakraborty Sukanya,Bhat Aaqib M.,Mushtaq Insha,Luan Haitao,Kalluchi Achyuth,Mirza Sameer,Storck Matthew D.,Chaturvedi Nagendra,Lopez- Guerrero Jose Antonio,Llombart-Bosch Antonio,Machado Isidro,Scotlandi Katia,Meza Jane L.,Ghosal Gargi,Coulter Donald W.,Rowley M Jordan,Band Vimla,Mohapatra Bhopal C.,Band Hamid
Abstract
ABSTRACTOverexpression of EPS15 Homology Domain containing 1 (EHD1) has been linked to tumorigenesis but whether its core function as a regulator of intracellular traffic of cell surface receptors plays a role in oncogenesis remains unknown. We establish that EHD1 is overexpressed in Ewing sarcoma (EWS), with high EHD mRNA expression specifying shorter patient survival. ShRNA and CRISPR-knockout with mouseEhd1rescue established a requirement of EHD1 for tumorigenesis and metastasis. RTK antibody arrays identified the IGF-1R as a target of EHD1 regulation in EWS. Mechanistically, we demonstrate a requirement of EHD1 for endocytic recycling and Golgi to plasma membrane traffic of IGF-1R to maintain its surface expression and downstream signaling. Conversely, EHD1 overexpression-dependent exaggerated oncogenic traits require IGF-1R expression and kinase activity. Our findings define the RTK traffic regulation as a proximal mechanism of EHD1 overexpression-dependent oncogenesis that impinges on IGF-1R in EWS, supporting the potential of IGF-1R and EHD1 co-targeting.
Publisher
Cold Spring Harbor Laboratory